Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City

被引:153
作者
Quale, J [1 ]
Bratu, S [1 ]
Landman, D [1 ]
Heddurshetti, R [1 ]
机构
[1] SUNY Downstate, Div Infect Dis, Brooklyn, NY 11203 USA
关键词
D O I
10.1086/375821
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multidrug-resistant Acinetobacter baumannii has emerged as a serious nosocomial pathogen in certain areas. In Brooklyn, New York, citywide surveillance revealed that similar to2 of every 3 isolates were resistant to carbapenem antibiotics. Genetic fingerprinting revealed that 2 strains accounted for 82% of these resistant isolates. Compared with carbapenem-susceptible isolates, carbapenem-resistant isolates had reduced expression of 47-, 44-, and 37-kDa outer-membrane proteins. No specific carbapenemase was found; however, carbapenem-resistant isolates expressed greater levels of a class C cephalosporinase. Although expression of penicillin-binding proteins varied among strains, no consistent pattern appeared to account for carbapenem resistance. An efflux pump, present in several strains, did not appear to contribute to carbapenem resistance. Clonal spread of carbapenem-resistant A. baumannii has occurred in hospitals in Brooklyn. The preliminary findings for a small number of strains suggest that diminished production of outer-membrane porins, together with increased expression of a class C cephalosporinase, appear to be important factors leading to carbapenem resistance in this region.
引用
收藏
页码:214 / 220
页数:7
相关论文
共 37 条
[1]   Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].
Afzal-Shah, M ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588
[2]  
AMES GFL, 1974, J BIOL CHEM, V249, P634
[3]  
[Anonymous], 1998, M100S8 NCCLS
[4]   EMERGENCE OF QUINOLONE-IMIPENEM CROSS-RESISTANCE IN PSEUDOMONAS-AERUGINOSA AFTER FLUOROQUINOLONE THERAPY [J].
AUBERT, G ;
POZZETTO, B ;
DORCHE, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) :307-312
[5]   OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J].
Bou, G ;
Oliver, A ;
Martínez-Beltran, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1556-1561
[6]   Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii [J].
Bou, G ;
Martínez-Beltrán, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :428-432
[7]   Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases [J].
Bou, G ;
Cerveró, G ;
Domínguez, MA ;
Quereda, C ;
Martínez-Beltrán, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3299-3305
[8]   Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2 [J].
Brown, S ;
Bantar, C ;
Young, HK ;
Amyes, SGB .
LANCET, 1998, 351 (9097) :186-187
[9]   IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998 [J].
Chu, YW ;
Afzal-Shah, M ;
Houang, ETS ;
Palepou, MFI ;
Lyon, DJ ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :710-714
[10]   Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein [J].
Clark, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :245-251